Bain's latest acquisition follows a string of hefty investments the private equity firm has made in Japan in recent months.

Oppenheimer initiated coverage of ARS Pharmaceuticals (SPRY) with an Outperform rating and $40 price target As the first and only approved ...

Wall St ends lower as White House says Trump to implement tariffs February 1, 2025 The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

OKYO Pharma (OKYO) has been notified that the CEO Gary Jacob has purchased 10,000 of the Company’s ordinary shares on NASDAQ at a price of $1.04 per share. The company said, “We have also been ...

Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil E-mail: [email protected] ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...

NORTHFIELD, Minn., Jan. 28, 2025 /PRNewswire/ -- Aurora Pharmaceutical, a leading manufacturer of animal health products, is excited to announce the appointment of Stephanie Hastings as its new ...